Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation.
AUTHORS
Hermanson
DJDaniel J ,
Hartley
ND Nolan D ,
Gamble-George
J Joyonna ,
Brown
N Naoko ,
Shonesy
BC Brian C ,
Kingsley
PJ Phillip J ,
Colbran
RJ Roger J ,
Reese
J Jeffrey ,
Marnett
LJ Lawrence J ,
Patel
S Sachin .
Nature neuroscience. 2013 9 ; 16(9).
1291-8
- PMID: 23912944[PubMed].
- PMCID: PMC3788575.
- NIHMSID: NIHMS499735